Upstart,
I would agree with you if it was an issue of their control or making. However, it is a sovereign Government's change in policy/ tax arrangements and the company has previously said they are well-placed to deal with changes to the tax arrangements for this one channel to the Chinese market.
On this occasion it's best to let management deal with items they can control. This is not a big impact on our target sales numbers when all is said and done.
- Forums
- ASX - By Stock
- A2M
- Explain China new tax policy and formula registration with CFDA
Explain China new tax policy and formula registration with CFDA, page-71
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
|
|||||
Last
$6.85 |
Change
0.000(0.00%) |
Mkt cap ! $4.952B |
Open | High | Low | Value | Volume |
$6.88 | $6.90 | $6.83 | $929.8K | 135.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 41 | $6.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.86 | 19698 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 14952 | 6.840 |
15 | 13478 | 6.830 |
14 | 24813 | 6.820 |
13 | 36338 | 6.810 |
6 | 8198 | 6.800 |
Price($) | Vol. | No. |
---|---|---|
6.860 | 21208 | 17 |
6.870 | 14933 | 10 |
6.880 | 22931 | 12 |
6.890 | 8504 | 9 |
6.900 | 25431 | 6 |
Last trade - 10.40am 16/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online